Clinical Trials on Behavior, Risk in Mexico
Total 859 results
-
Denovo Biopharma LLCCompletedSchizophreniaUnited States, Mexico, Germany, Russian Federation
-
Donald C. Goff, MDPfizerCompletedSchizophreniaUnited States
-
ShireCompletedHunter Syndrome | Mucopolysaccharidosis (MPS)United States, Argentina, Mexico, Spain, United Kingdom
-
Naurex, Inc, an affiliate of Allergan plcCompletedDepressive Disorder, MajorUnited States
-
Eli Lilly and CompanyCompletedDepressive Disorder, MajorUnited States, Finland, Poland, Russian Federation, Argentina
-
H. Lundbeck A/SCompletedMajor Depressive DisorderSpain, Czechia, Slovakia, Estonia, Sweden, Argentina, Belgium, Bulgaria, Latvia, Mexico, Russian Federation, Ukraine
-
Novo Nordisk A/SDuke Clinical Research InstituteNot yet recruitingCardiovascular Risk | Acute Myocardial Infarction (AMI)Canada, China, United States, Germany, Spain, Korea, Republic of, Netherlands, Australia, Italy, Denmark, India, United Kingdom, Argentina, Turkey, Mexico, Malaysia, Czechia, Poland, Brazil, France, Japan, Bulgaria, Greece, Israel
-
Eli Lilly and CompanyCompletedMajor Depressive DisorderUnited States, Germany, Italy, Turkey, Russian Federation, Korea, Republic of, Greece, France, Croatia, Romania, Spain, Argentina, Puerto Rico, Belgium, Mexico, Slovakia
-
Sirtsei Pharmaceuticals, Inc.Rho, Inc.RecruitingMajor Depressive DisorderUnited States
-
University of PennsylvaniaNational Cancer Institute (NCI)Active, not recruitingQuality of Life | Ostomy | TelehealthUnited States
-
SanofiTerminatedAnxiety DisordersFrance, Russian Federation, Australia, Germany, Spain, Mexico, Hungary, Italy, Chile
-
AstraZenecaCompleted
-
University of WashingtonNational Institute for Occupational Safety and Health (NIOSH/CDC); The Center...Active, not recruitingMental Stress | Work Related Stress | Work-related Injury | Work-Related Condition | Harassment, Non-Sexual | Harassment, Sexual | Bullying, WorkplaceUnited States
-
University of WashingtonCompletedBehavior TherapyUnited States
-
Columbia UniversityNational Institute on Drug Abuse (NIDA); University of Miami; Emory University; The Emmes Company, LLCRecruitingSubstance Use Disorders | Injection Site InfectionUnited States
-
Eli Lilly and CompanyCompletedSchizophrenia | Schizoaffective DisordersUnited States, Puerto Rico, Mexico, Brazil, Israel, Korea, Republic of, Russian Federation
-
University of New MexicoNational Institute on Drug Abuse (NIDA)CompletedDrug AbuseUnited States
-
Relmada Therapeutics, Inc.RecruitingDepression | Major Depressive DisorderUnited States
-
PfizerCompletedMajor Depressive DisorderUnited States, Mexico
-
SunovionCompleted
-
Timothy Morgan, MDNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Completed
-
Transcept PharmaceuticalsTerminatedObsessive-compulsive DisorderUnited States, Mexico
-
PfizerCompletedMajor Depressive DisorderUnited States, Chile, Mexico
-
AstraZenecaCompletedAcute Bipolar DepressionBrazil, Mexico, Peru, Turkey, Argentina, Chile, Venezuela, Colombia, Guatemala
-
BiogenCompletedDepressive Disorder, MajorUnited States
-
NYU Langone HealthNational Institute on Drug Abuse (NIDA); The Emmes Company, LLCCompletedOpioid Use DisorderUnited States
-
Northwell HealthBoston University; University of Pittsburgh; Dartmouth-Hitchcock Medical CenterCompletedSchizophrenia | Schizoaffective Disorder | Psychosis NOSUnited States
-
Denovo Biopharma LLCTerminatedSchizophreniaUnited States, Mexico, Russian Federation, Puerto Rico, Ukraine
-
BiogenTerminatedMajor Depressive DisorderUnited States
-
H. Lundbeck A/STakedaCompletedDepressive Disorder, MajorUnited States, Bulgaria, Canada, Colombia, Estonia, France, Germany, Hungary, Italy, Korea, Republic of, Latvia, Mexico, Poland, Russian Federation, Serbia, South Africa, Spain, Ukraine, United Kingdom
-
VA Office of Research and DevelopmentCompletedMajor Depressive DisorderUnited States
-
H. Lundbeck A/STakedaCompletedDepressive Disorder, MajorKorea, Republic of, United States, Hungary, Poland, Spain, Serbia, Estonia, Bulgaria, Mexico, Russian Federation, Ukraine, Canada, Colombia, France, Germany, Israel, Italy, Latvia, South Africa
-
Eli Lilly and CompanyCompletedSchizophreniaGermany, Mexico, Austria, Croatia, Romania, Russian Federation, Argentina, Portugal, South Africa
-
Eli Lilly and CompanyCompletedAnxiety Neuroses | Anxiety States, Neurotic | Neuroses, AnxietyUnited States, Mexico, South Africa
-
PfizerCompletedAnxiety DisordersUnited States
-
PfizerCompletedMajor Depressive DisorderUnited States, Mexico
-
AstraZenecaCompletedMajor Depressive DisorderUnited States
-
Johns Hopkins UniversityVirginia Commonwealth UniversityCompletedSubstance-Related DisordersUnited States
-
Denovo Biopharma LLCCompletedTreatment Resistant DepressionUnited States, Canada
-
Merck Sharp & Dohme LLCTerminatedTreatment Resistant DepressionUnited States
-
Bristol-Myers SquibbCompletedMajor Depressive DisorderUnited States
-
MSI Methylation Sciences, Inc.CompletedMajor Depressive Disorder (MDD)United States
-
Sage TherapeuticsBiogenCompletedMajor Depressive DisorderUnited States
-
Rexahn Pharmaceuticals, Inc.CompletedMajor Depressive DisorderUnited States
-
University of California, San FranciscoPfizerCompletedOveractive Bladder | Urge Urinary IncontinenceUnited States
-
Otsuka Pharmaceutical Development & Commercialization...RecruitingAgitation in Patients With Dementia of the Alzheimer's TypeUnited States, Belgium, Canada, Chile, Colombia, Croatia, Hungary, Mexico, Netherlands, Slovakia, Slovenia, Spain, Ireland
-
Janssen Research & Development, LLCCompletedTreatment-resistant DepressionUnited States, France, Belgium, Mexico, Canada, Brazil, Estonia, Hungary, Slovakia
-
AstraZenecaCompletedMajor Depressive DisorderKorea, Republic of, Mexico, South Africa, China, Finland, Canada, Spain, Philippines, Malaysia
-
Eisai Inc.Thrombolysis In Myocardial Infarction (TIMI) Academic Research OrganizationCompletedObesity | Cardiovascular Disease | Overweight | Type 2 Diabetes | High Cardiovascular RiskUnited States, Canada, Poland, Australia, Mexico, New Zealand, Bahamas, Chile